Sun, 09-Aug-2020
Monday 06 Jul 2020 , 12:35 pm

Emergent Signs Five-year Deal Backing J&J COVID-19 Vaccine

Under the deal, starting next year Emergent will provide large-scale manufacturing services to produce the drug substance over five years, with the first two years valued at about $480 million.
By SIN Bureau
Share at:

Emergent BioSolutions Inc. said on Monday it had signed a five-year pact to make the drug substance used in Johnson & Johnson’s COVID-19 vaccine candidate, adding to a series of contracts likely to put it at the heart of future global vaccine production.

Under the deal, starting next year Emergent will provide large-scale manufacturing services to produce the drug substance over five years, with the first two years valued at about $480 million.

The news follows a $135 million deal struck by the two companies in April, to use Emergent’s manufacturing facilities to help make more than 1 billion doses of the vaccine J&J is testing to stop the coronavirus.

Emergent has also signed similar deals to expand the manufacturing capacity of COVID-19 vaccines under development by AstraZeneca Plc, Novavax Inc and Vaxart Inc.

The company last month also agreed a $628 million contract with the U.S. government, which is looking to secure manufacturing capacity for a potential COVID-19 vaccine under its “Operation Warp Speed” program.

Read Here




Neha Mule

Neha writes articles on sectors including medicine, food, materials, and science & technology. A qualified statistician, she has the ability to observe and analyze the trends in global markets and write compelling articles that help CXOs in decision making. She is a bookworm and loves to read fiction, lifestyle, science and technology. Neha comes with 6 years of experience in content writing and editing that involves blog writing, preparation of study materials and OERs.

More from Neha Mule

Smart News, Updates and Insights Drive Smarter Decisions

Smart Industry News is a one stop shop of industry news across the globe. We have a team of experts who provides latest updates on industry news to our readers daily. The news available on our website is general information and does not provide our customers with any legal or professional advice specific to any industry...

sales@smartindustrynews.com
media@smartindustrynews.com

Subscribe to our newsletter
Get the latest in your inbox weekly Sign up for the fully charged newsletter
Follow Us:
© The News and Media Division of The Insight Partners 2019 | All Rights Reserved